feed,title,long_url,short_url
SeekingAlpha,Stem joins Russell 2000 Index,https://seekingalpha.com/news/3710352,
SeekingAlpha,Kymera Therapeutics reports positive interim data from SAD portion of early-stage KT-474 trial,https://seekingalpha.com/news/3710353,
